PBYI Puma Biotechnology Inc

Price (delayed)

$9.88

Market cap

$398.78M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.67

Enterprise value

$415.41M

Highlights
Puma Biotechnology's equity has surged by 75% YoY
The net income has soared by 68% YoY and by 56% from the previous quarter
Puma Biotechnology's quick ratio has decreased by 34% YoY and by 8% from the previous quarter
Puma Biotechnology's gross margin has decreased by 6% YoY and by 5% from the previous quarter

Key stats

What are the main financial stats of PBYI
Market
Shares outstanding
40.36M
Market cap
$398.78M
Enterprise value
$415.41M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
24.2
Price to sales (P/S)
1.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.53
Earnings
Revenue
$272.06M
EBIT
-$11.86M
EBITDA
-$793,000
Free cash flow
$27.93M
Per share
EPS
-$0.67
Free cash flow per share
$0.69
Book value per share
$0.41
Revenue per share
$6.76
TBVPS
$4.63
Balance sheet
Total assets
$258.66M
Total liabilities
$242.22M
Debt
$121.13M
Equity
$16.44M
Working capital
$23.36M
Liquidity
Debt to equity
7.37
Current ratio
1.17
Quick ratio
1.03
Net debt/EBITDA
-20.97
Margins
EBITDA margin
-0.3%
Gross margin
78%
Net margin
-9.8%
Operating margin
1.5%
Efficiency
Return on assets
-10.3%
Return on equity
-317.4%
Return on invested capital
-13.7%
Return on capital employed
-10%
Return on sales
-4.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PBYI stock price

How has the Puma Biotechnology stock price performed over time
Intraday
-3.23%
1 week
-12.95%
1 month
-2.76%
1 year
-2.56%
YTD
-3.7%
QTD
1.65%

Financial performance

How have Puma Biotechnology's revenue and profit performed over time
Revenue
$272.06M
Gross profit
$212.21M
Operating income
$4M
Net income
-$26.53M
Gross margin
78%
Net margin
-9.8%
The operating income has soared by 113% from the previous quarter and by 106% YoY
The operating margin has soared by 111% from the previous quarter and by 105% YoY
Puma Biotechnology's net margin has surged by 73% YoY and by 63% QoQ
The net income has soared by 68% YoY and by 56% from the previous quarter

Growth

What is Puma Biotechnology's growth rate over time

Valuation

What is Puma Biotechnology stock price valuation
P/E
N/A
P/B
24.2
P/S
1.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.53
PBYI's EPS has surged by 68% year-on-year and by 56% since the previous quarter
Puma Biotechnology's equity has surged by 75% YoY
PBYI's P/B is 19% lower than its 5-year quarterly average of 29.9
The revenue has grown by 21% YoY and by 21% from the previous quarter
PBYI's P/S is 14% below its last 4 quarters average of 1.7

Efficiency

How efficient is Puma Biotechnology business performance
PBYI's return on sales has surged by 86% year-on-year and by 78% since the previous quarter
The ROA has soared by 71% YoY and by 57% QoQ
PBYI's ROIC has soared by 69% QoQ and by 69% YoY
Puma Biotechnology's ROE has soared by 65% from the previous quarter and by 37% YoY

Dividends

What is PBYI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PBYI.

Financial health

How did Puma Biotechnology financials performed over time
The total assets is 7% more than the total liabilities
Puma Biotechnology's quick ratio has decreased by 34% YoY and by 8% from the previous quarter
The company's current ratio fell by 33% YoY and by 9% QoQ
Puma Biotechnology's debt to equity has surged by 136% QoQ but it has decreased by 43% YoY
Puma Biotechnology's equity has surged by 75% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.